NEW YORK (GenomeWeb News) – Bayer Schering Pharma will used Roche’s xCELLigence System for real-time non-labeled cell analysis, Roche Applied Science said today.
 
Roche said Bayer is one of the first users of the recently introduced xCELLigence System, which is designed for a variety of applications including short-term kinetic analysis and assays for cell proliferation and cytotoxicity. Manfred Baier, head of Roche Applied Science, said that the firm expects pharma research to be a primary application area for the new system.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.